Background
Metformin is a pharmacological candidate to mitigate second-generation antipsychotic (SGA)-induced weight gain in patients diagnosed with severe mental illnesses (SMI).
ObjectiveTo determine the incidence, prevalence and demographic patterns of metformin co-prescription among patients diagnosed with SMI initiating SGAs. To estimate...
It’s pretty amazing how much nature offers us when it comes to healing and feeling better — whether that’s through natural remedies, time spent outside, or...